Furthermore, COX-2-driven prostaglandin E2 (PGE-2) biosynthesis is related to a plethora of aggressive carcinogenic mechanisms in BC, having been proposed as a promising therapeutic target and also being associated with a poorer prognosis [17,38]. This evidence concerns the gene PTGS2 and breast cancer.